Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QS2B
|
|||
| Drug Name |
N-(pyridin-2-yl)pyrimidin-4-amine derivative 2
|
|||
| Synonyms |
PMID26161698-Compound-31
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BAYER PHARMA AKTIENGESELLSCHAFT
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17F4N5O2S
|
|||
| Canonical SMILES |
COC1=C(C=CC(=C1)F)C2=CC(=NC=N2)NC3=CC(=CC(=N3)C(F)(F)F)CS(=N)(=O)C
|
|||
| InChI |
1S/C19H17F4N5O2S/c1-30-15-7-12(20)3-4-13(15)14-8-17(26-10-25-14)28-18-6-11(9-31(2,24)29)5-16(27-18)19(21,22)23/h3-8,10,24H,9H2,1-2H3,(H,25,26,27,28)
|
|||
| InChIKey |
BYCJOJLDGATDTD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.